kbvresearch

Global Cardiac Biomarkers Testing Market to reach a market size of $16.2 billion by 2025- KBV Research

Press release   •   Aug 19, 2019 16:19 IST

According to a new report Global Cardiac Biomarkers Testing Market, published by KBV research, The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period.

The North America market dominated the Global Creatine Kinase (CK-MB) Market by Region in 2018, growing at a CAGR of 9.9 % during the forecast period. The Europe market is expected to witness a CAGR of 10.3% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 12% during (2019-2025).

The Myocardial Infarction market dominated the Global Cardiac Biomarkers Testing Market by Application in 2018, growing at a CAGR of 11 % during the forecast period. The Congestive Heart Failure market is expected to witness a CAGR of 12.5% during (2019-2025). Additionally, The Acute Coronary Syndrome market is expected to witness highest CAGR of 10.9% during (2019-2025).

The Laboratory Testing market dominated the Global Cardiac Biomarkers Testing Market by Location of Testing in 2018, growing at a CAGR of 10.3 % during the forecast period. The Point of Care Testing market is expected to witness highest CAGR of 13.6% during (2019-2025).

Full Report: https://www.kbvresearch.com/cardiac-biomarkers-testing-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.

Global Cardiac Biomarkers Testing Market Segmentation

By Type

Creatine Kinase (CK-MB)

Troponins

Myoglobin

Natriuretic Peptides (BNP and NT-proBNP)

Ischemia Modified Albumin

Others

By Application

Myocardial Infarction

Congestive Heart Failure

Acute Coronary Syndrome

Atherosclerosis

Others

By Location of Testing

Point of Care Testing

Laboratory Testing

By Geography

North America

US

Canada

Mexico

Rest of North America

Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

Trivitron Healthcare Pvt. Ltd.

Abbott Laboratories

Siemens AG

Becton, Dickinson AND Company

Bio-Rad Laboratories, Inc.

Randox Laboratories Limited

Danaher Corporation

Thermo Fisher Scientific, Inc.

Johnson and Johnson

Quidel Corporation

Cardiac Biomarkers Testing Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

Over the years, Market research has been an important component of strategic decision making processes. Market research activities have been facilitating the search for new market opportunities, understanding the market gap, bringing in the key insights into the R & D departments, value addition to marketing and promotional functions and many more. In short, one can say that the market research has been a fog light to various industries, especially while taking strategic decisions.

KBV Research is Knowledge Based Value Research, which is a global brand and consulting firm serving all kinds of business verticals, government and non-governmental organizations, and not-for-profit organizations. Our motto is to extend our services that will have a lasting impact on our clients who trust us with their business goals. KBV Research is a global market research and consulting company offering syndicated and custom market research reports with exhaustive industry analysis.